Search Media Items

Testicular cancer treatment options depend upon tumor type, stage, and risk group and include surgery, radiation, chemotherapy, and surveillance. Get detailed treatment information about for newly diagnosed and recurrent testicular cancer in this summary for clinicians.

Gestational trophoblastic disease treatment depends on the specific type and risk category, and may include surgery, chemotherapy, and radiation. Get detailed information about the diagnosis and treatment of newly diagnosed and recurrent disease in this summary for clinicians.

Small intestine cancer treatment is surgery when resection is possible. Surgical bypass, palliative radiation therapy, and chemotherapy are options for unresectable or recurrent tumors. Get detailed treatment information for small intestine cancer in this summary for clinicians.

Carcinoma of unknown primary (CUP) treatment depends on the best determination of the primary site, if possible. Treatment options may include surgery, radiation therapy, and systemic treatment. Get detailed information about diagnosis and treatment of CUP in this summary for clinicians.

Transitional cell cancer of the renal pelvis and ureter treatment is primarily surgery. In metastatic or recurrent disease, chemotherapy regimens for metastatic bladder cancer are often used. Get detailed treatment information for newly diagnosed and recurrent disease in this clinician summary.

Uterine sarcoma treatment is primarily surgery, with or without radiation or chemotherapy. Get detailed information about the treatment options for newly diagnosed or recurrent uterine sarcoma cancer in this summary for clinicians.

Resumen de información revisada por expertos sobre el uso de los extractos de muérdago como tratamiento para personas con cáncer.

Treatment options for children with vascular tumors are limited and efficacy has not been validated in prospective clinical trials. Historically therapies have been mostly to palliate symptoms. Get detailed information about the types of vascular tumors in this clinician summary.

El NCI está trabajando para entender y responder a las desigualdades en salud por cáncer, como lo son los índices más altos de mortalidad, menos frecuencia en el uso de exámenes de detección comprobados e índices más altos en el diagnóstico de cánceres avanzados en ciertos grupos de la población en comparación con otros.

In this phase I clinical trial, HIV-positive patients receiving combination antiretroviral therapy who have cancer that has recurred after or has not responded to previous treatment will receive the immune checkpoint inhibitor pembrolizumab.